NASDAQ:TDACU Translational Development Acquisition (TDACU) Stock Price, News & Analysis $11.50 -0.61 (-5.04%) Closing price 10/5/2026 07:00 AM EasternExtended Trading$11.50 0.00 (0.00%) As of 10/5/2026 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC Filings About Translational Development Acquisition Stock (NASDAQ:TDACU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get TDACU alerts:Sign Up Key Stats Today's Range$12.11▼$12.6550-Day Range$11.50▼$13.0952-Week Range$10.71▼$17.29Volume202 shsAverage Volume2,185 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Translational Development Acquisition Corporation is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating companies. Rather than selling products or services of its own, the company raises capital through a public offering and holds those funds while it evaluates potential merger, acquisition, or similar opportunities. The company has indicated that it is seeking a target in the healthcare and life sciences sectors, although its business activities may change substantially if it completes a transaction. Until then, Translational Development Acquisition Corporation has no established operating business, product portfolio, or geographic customer base. Translational Development Acquisition Corporation’s units trade on the Nasdaq under the symbol TDACU. The units generally represent an interest consisting of common stock and related warrant securities, subject to the terms of the company’s offering documents. Publicly available information about its leadership and potential acquisition targets is limited.AI Generated. May Contain Errors. Read More Receive TDACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Translational Development Acquisition and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TDACU Stock News HeadlinesTranslational Development Acquisition Corp.September 9, 2026 | fool.comProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business CombinationJuly 29, 2026 | uk.finance.yahoo.comYour backdoor link (still works)Bill Poulos is offering a private link to download his book Simple Options Trading For Beginners, bypassing the usual $29.97 checkout entirely. The page isn't listed anywhere on his site. Once it closes, the standard checkout becomes the only way in. | Profits Run (Ad)TDAC Advances ProLogium De-SPAC with SEC FilingJuly 8, 2026 | tipranks.comTranslational Development Acquisition Corp. UnJuly 4, 2026 | barrons.comTDAC Shareholders Back SPAC Extension Amid ProLogium DealJune 23, 2026 | tipranks.comTranslational Development Acquisition Wins Approval for SPAC ExtensionJune 18, 2026 | tipranks.comSponsor Converts Class B Shares to Class AJune 12, 2026 | tipranks.comSee More Headlines TDACU Stock Analysis - Frequently Asked Questions How have TDACU shares performed this year? Translational Development Acquisition's stock was trading at $10.44 on January 1st, 2026. Since then, TDACU shares have increased by 10.2% and is now trading at $11.50. When did Translational Development Acquisition IPO? Translational Development Acquisition (TDACU) raised $150 million in an IPO on the week of December 23rd 2024. The company issued 15,000,000 shares at $10.00 per share. How do I buy shares of Translational Development Acquisition? Shares of TDACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 TDACU's financial health is in the Green zone, according to TradeSmith. TDACU has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:TDACU Previous SymbolOTCMKTS:TDACU CIK1926599 Webwww.translational-development.com Phone(413) 204-2769FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:TDACU) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredMAJOR BUY ALERT: Elon, Data Centers, SpaceStock picker Luke Lango recently toured Vegas and counted more than 60 new data centers under construction, ev...InvestorPlace | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredThe AI Stock to Keep an Eye on Before Election Day (See Why)In 2019, Charles Mizrahi named Marvell Technology his top AI pick. It's since climbed 1300 percent. Now he'...Prosperity Research | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredThese are the last great retirement income stocks in AmericaOnly 52 of the S&P 500's 500 companies still pay dividend yields of 4% or better. Just 18 pay 5%, and only 8 p...Market Savvy | Sponsored“Whoever wins AI, wins”Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Translational Development Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Translational Development Acquisition With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.